About VClinBio
VClinBio is a Healthcare company based in Chennai (India) founded in 2013. Operator of a collection of lifestyle hotels. VClinBio has raised $3.9 million across 1 funding round. The company has 1 employees. Its Indian entity V Clinbio Labs Private Limited reported revenue of ₹2.4 Lakh. VClinBio offers products and services including Novel Prodrugs and Drug Repurposing Services. Its focus areas include Medical Research Labs.
Company details
VClinBio was established in 2013 in Chennai, India, within the hospitality sector. A portfolio of lifestyle hotels is managed, with accommodations offered in renovated historical buildings. Historical elements are integrated with modern amenities across the properties. Dining options, spa facilities, and event spaces are provided as part of the services. Operations emphasize blending heritage with contemporary functionality in the Indian market.
- Headquarters Chennai, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website vclinbio.com
- Social LinkedIn X Facebook
- Legal Name V Clinbio Labs Private Limited
- Date of Incorporation 05 Sep, 2013
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹2.4 Lakh
FY 2021
- Net Loss-₹15.5 Lakh
FY 2021 · -655% margin
- EBITDA-₹15.5 Lakh
FY 2021 · -655% margin
- Total Equity Funding$3.9M (USD)
in 1 rounds
- Latest Funding Round$3.9M (USD), Series A
Aug 2017
- Employee Count1
Associated legal entities of VClinBio
VClinBio operates through V Clinbio Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| V Clinbio Labs Private Limited CIN U73100TN2013PTC092866 | Active | 05 Sep 2013 | Chennai, Tamil Nadu | ₹0.0 Cr | 1 | 3 | View details |
Products & Services of VClinBio
VClinBio offers a comprehensive portfolio of products and services, including Novel Prodrugs and Drug Repurposing Services.
Novel prodrugs are developed by conjugating fatty acids with approved therapeutics to improve pharmacokinetic and pharmacodynamic properties.
Drug repurposing is performed by adapting existing agents for new indications through incremental innovation.
Funding Insights of VClinBio
VClinBio has successfully raised a total of $3.9M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.9 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.9M
- Total Rounds 1
- Last Round Series A — $3.9M
- First Round $3.9M
(Aug 2017)
All 1 funding rounds of VClinBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2017 | $3.9M | Series A | – | – | – |
Board of directors of V Clinbio Labs Private Limited (VClinBio)
V Clinbio Labs Private Limited is the primary company behind VClinBio. The board of V Clinbio Labs Private Limited currently have 3 directors; the longest-serving is Subramaniam Apparsundaram, appointed in 2013.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subramaniam Apparsundaram DIN 06671538 | Managing Director | 05 Sep 2013 | 13 yrs 1 mo | V Clinbio Labs Private Limited |
| Apparsundaram Kandaswamy DIN 06671557 | Director | 05 Sep 2013 | 13 yrs 1 mo | V Clinbio Labs Private Limited |
| Apparsundram Rajanikanth DIN 06671547 | Director | 05 Sep 2013 | 13 yrs 1 mo | V Clinbio Labs Private Limited |
Financials of VClinBio
Figures of V Clinbio Labs Private Limited, the primary company behind VClinBio, for FY 2021. Revenue was ₹2.4 Lakh. Net loss was -₹15.5 Lakh (-655% margin). EBITDA was -₹15.5 Lakh (-655% margin). Revenue has grown at a compounded annual rate of -17% over three years and -45% over five years.
- ₹2.4 LakhRevenue · FY 2021
- -₹15.5 LakhNet loss · -655% margin
- -₹15.5 LakhEBITDA · -655% margin
- ₹1 LakhPaid-up capital
- 1Employees (provident fund records)
- -17%Revenue CAGR, 3 years
- -45%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of V Clinbio Labs Private Limited are on its company page.
Detailed financial statements for VClinBio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of VClinBio
2 dated milestones of VClinBio across 4 years, from founding to its latest funding, stage changes and deals.
- Founded VClinBio is founded.
- Funding First funding round of $3.9M.
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as VClinBio (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 50.52 M | 902 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vclinbio
Complete news archive for VClinBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VClinBio
VClinBio was founded in 2013 and raised its 1st funding round 4 years after it was founded.
VClinBio is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
VClinBio is a funded company, having raised a total of $3.9M across 1 funding round to date. The company's 1st funding round was a Series A of $3.9M, raised on Aug 2017.
VClinBio has 1 employees.
The primary company behind VClinBio, V Clinbio Labs Private Limited, reported revenue of ₹2.4 Lakh for FY 2021.
VClinBio was established in 2013 in Chennai, India, within the hospitality sector. A portfolio of lifestyle hotels is managed, with accommodations offered in renovated historical buildings. Historical elements are integrated with modern amenities across the properties. Dining options, spa facilities, and event spaces are provided as part of the services. Operations emphasize blending heritage with contemporary functionality in the Indian market.
VClinBio offers Novel Prodrugs and Drug Repurposing Services.
VClinBio operates through V Clinbio Labs Private Limited.
The legal entities of VClinBio currently have 3 directors, including Subramaniam Apparsundaram, Apparsundaram Kandaswamy, Apparsundram Rajanikanth.